Document:

Form of Employment Agreement - each of its executive officers

 EXHIBIT 10.10 
 NATUS MEDICAL INCORPORATED 
                                        
  EMPLOYMENT AGREEMENT 
 This Agreement is entered into as of
                    , (the “Effective Date”) by and between Natus Medical Incorporated (the “Company”), and
                                        
(“Executive”). 
 1. Duties and Scope of Employment. 
 (a) Positions and Duties. As of the Effective Date, Executive will serve as
                                        
of the Company. Executive will render such business and professional services in the performance of his duties, consistent with Executive’s position within the Company, as shall reasonably be assigned to him by the Company’s Chief
Executive Officer (“CEO”). The period of Executive’s employment under this Agreement is referred to herein as the “Employment Term.” 
 (b) Obligations. During the Employment Term, Executive will perform his duties faithfully and to the best of his ability and will devote his full business efforts and time to the Company.
For the duration of the Employment Term, Executive agrees not to actively engage in any other employment, occupation or consulting activity for any direct or indirect remuneration without the prior approval of the Board. 
 2. At-Will Employment. The parties agree that Executive’s employment with the Company will be “at-will” employment
and may be terminated at any time with or without cause or notice. Executive understands and agrees that neither his job performance nor promotions, commendations, bonuses or the like from the Company give rise to or in any way serve as the basis
for modification, amendment, or extension, by implication or otherwise, of his employment with the Company. 
 3.
Compensation. 
 (a) Base Salary. During the Employment Term, the Company will pay Executive an annual salary of
$             as compensation for his services (the “Base Salary”). The Base Salary will be paid periodically in accordance with the Company’s normal payroll practices
and be subject to the usual, required withholding. Executive’s salary will be subject to review and adjustments will be made based upon the Company’s normal performance review practices. 
 4. Employee Benefits. During the Employment Term, Executive will be entitled to participate in the employee benefit plans
currently and hereafter maintained by the Company of general applicability to other senior executives of the Company, including, without limitation, the Company’s group medical, dental, vision, disability, life insurance, and flexible-spending
account plans. The Company reserves the right to cancel or change the benefit plans and programs it offers to its employees at any time. 
  

 -1- 

 5. Paid Time Off (“PTO”). Executive will be entitled to receive PTO
pursuant to Natus’ standard benefit policy currently and hereafter maintained by the Company, and as may be cancelled or changed from time to time. 
 6. Expenses. The Company will reimburse Executive for reasonable travel, entertainment or other expenses incurred by Executive in the furtherance of or in connection with the performance of Executive’s
duties hereunder, in accordance with the Company’s expense reimbursement policy as in effect from time to time. 
 7.
Severance. 
 (a) Involuntary Termination. If
Executive’s employment with the Company terminates other than for “Cause” (as defined herein), death or disability, and Executive signs and does not revoke a standard release of claims with the Company, then, subject to
Section 11, Executive shall be entitled to (i) receive continuing payments of severance pay (less applicable withholding taxes) at a rate equal to his Base Salary rate, as then in effect, for a period equal to
             months, plus              month for each             
months of employment, up to a maximum of              month(s) from the date of such Executive’s “separation from service” (as defined in Treas. Reg. 1.409A-1(h)) with the
Company, to be paid periodically in accordance with the Company’s normal payroll policies and commencing with the latest payroll date that is also within seventy (70) days from the date of “separation from service” (with earlier
commencement possible only if in compliance with Section 409A of the code and with payments that would have been made on earlier payroll dates, but for this provision, cumulated and paid on such payroll date); (ii) the immediate vesting
and exercisability of             % of the shares subject to all of Executive’s stock awards covering shares of Company Common Stock (whether currently outstanding or granted in
following the Effective Date) outstanding on the date such release of claims becomes effective (the “Stock Awards”) and (iii) continued payment by the Company of the group health continuation coverage premiums for Executive and
Executive’s eligible dependents under Title X of the Consolidated Budget Reconciliation Act of 1985, as amended (“COBRA”) as in effect through the lesser of
(x)              months from the effective date of such termination, (y) the date upon which Executive and Executive’s eligible dependents become covered under similar plans,
or (z) the date Executive no longer constitutes a “Qualified Beneficiary” (as such term is defined in Section 4980B(g) of the Internal Revenue Code of 1986, as amended (the “Code”)); provided, however, that
Executive will be solely responsible for electing such coverage within the required time periods. Compensation and benefits payable pursuant to this provision that are made from the date of “separation from service” with the Company
through March 15th of the calendar year following such termination, are intended to constitute separate payments for purposes of Treas. Reg.
1.409A-2(b)(2) and thus payable pursuant to the “shot-term deferral” rule set forth in Treas. Reg. 1.409A-1(b)(4); payments made following such March 15th, are intended to constitute separate payments for purposes of Treas. Reg. 1.409A-2(b)(2) made upon an involuntary termination from service and payable pursuant to Treas. Reg. 1.409A-1(b)(9)(iii), to the maximum
extent permitted by said provision, with any excess amount being regarded as subject to the distribution requirements of Section 409A(a)(2)(A) of the Code, including, without limitation, the requirement of Section 409A(a)(2)(B)(i) of the
code that payments be delayed until six months after “separation from service” if Executive is a “specified employee” within the meaning of the aforesaid section of the Code at the time of such “separation from
service.” 
  

 -2- 

 (b) Voluntary Termination; Termination for Cause. If Executive’s employment
with the Company terminates voluntarily by Executive (other than as described in subsection (c) below) or for Cause by the Company or due to Executive’s death or disability, then (i) all vesting of Stock Options will immediately
cease, (ii) all payments of compensation by the Company to Executive hereunder will terminate immediately (except as to amounts already earned), and (iii) Executive will only be eligible for severance benefits, if any, in accordance with
the Company’s established policies as then in effect. 
 (c) Change of Control Benefits. If within twelve
(12) months following a “Change of Control” (as defined below) (i) Executive terminates Executive’s employment with the Company for Good Reason after providing the Company with written notice within the ninety (90) days
after the occurrence of an event constituting Good Reason and an opportunity for the Company to cure such occurrence of not less than thirty (30) days, or (ii) the Company or the successor corporation terminates Executive’s employment
with the Company for other than Cause, death or disability, then Executive shall be entitled to the benefits provided for in subsection (a). Executive shall only be permitted to receive the benefits provided for in subsection (a) once and shall
not be permitted to claim such benefits under both subsection (a) and (c) such that Executive would receive the benefits pursuant to subsection (a) twice. The payment-characterization provisions made under subsection (a) above
for purposes of Section 409A of the Code shall apply as well. 
 8. Limitation on Payments. In the event that the
severance and other benefits provided for in this Agreement or otherwise payable to the Executive (i) constitute “parachute payments” within the meaning of Section 280G of the Code and (ii) but for this Section 8, would
be subject to the excise tax imposed by Section 4999 of the Code, then the Executive’s severance benefits under Section 4(a)(i) shall be either: 
 delivered in full, or 
 delivered as to such lesser extent which would
result in no portion of such severance benefits being subject to excise tax under Section 4999 of the Code, 
 whichever of the
foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by Executive on an after-tax basis, of the greatest amount of severance benefits,
notwithstanding that all or some portion of such severance benefits may be taxable under Section 4999 of the Code. Unless the Company and Executive otherwise agree in writing, any determination required under this Section 8 shall be made
in writing by the Company’s independent public accountants immediately prior to Change of Control (the “Accountants”), whose determination shall be conclusive and binding upon Executive and the Company for all purposes. For
purposes of making the calculations required by this Section 8, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of
Sections 280G and 4999 of the Code. The Company and Executive shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section. The Company shall bear all
costs the Accountants may reasonably incur in connection with any calculations contemplated by this Section 8. If payment is to be in a lesser amount then reduction shall occur in the following order: (i) reduction of payments of cash; and
(ii) reduction in equity awards; and in each category reduction shall be pro rata between those payments subject to Section 409A and payments not subject to Section 409A. 
  

 -3- 

 9. Definitions. 
 (a) Cause. For purposes of this Agreement, “Cause” shall mean (i) any act of personal dishonesty taken by
Executive in connection with his responsibilities as an employee and intended to result in substantial personal enrichment of Executive, (ii) Executive’s conviction of a felony, (iii) a willful act by Executive which constitutes gross
misconduct and which is injurious to the Company, or (iv) continued substantial violations by Executive of Executive’s employment duties which are demonstrably willful and deliberate on Executive’s part after there has been delivered
to Executive a written demand for performance from the Company which specifically sets forth the factual basis for the Company’s belief that Executive has not substantially performed Executive’s duties. 
 (b) Change of Control. For purposes of this Agreement, “Change of Control” of the Company is defined as:

 (i) any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as
amended) is or becomes the “beneficial owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing 50% or more of the total voting power represented by the Company’s then
outstanding voting securities; or 
 (ii) a change in the composition of the Board occurring within a two-year period, as a
result of which fewer than a majority of the directors are Incumbent Directors. (“Incumbent Directors”) will mean directors who either (A) are directors of the Company as of the date hereof, or (B) are elected, or
nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such election or nomination (but will not include an individual whose election or nomination is in connection with an
actual or threatened proxy contest relating to the election of directors to the Company); or 
 (iii) the date of the
consummation of a merger or consolidation of the Company with any other corporation that has been approved by the stockholders of the Company, other than a merger or consolidation which would result in the voting securities of the Company
outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than forty percent (40%) of the total voting power represented by the
voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation, or the stockholders of the Company approve a plan of complete liquidation of the Company; or 
 (iv) the date of the consummation of the sale or disposition by the Company of all or substantially all the Company’s assets.

 (c) Good Reason. For purposes of this Agreement, “Good Reason” shall mean any of the following
actions taken without the Executive’s express written consent (i) the material reduction of the Executive’s duties or responsibilities relative to Executive’s duties or responsibilities in effect immediately prior to such
reduction; provided, however, that a reduction in duties or responsibilities solely by virtue of the Company being acquired and made part of a larger entity (as, for example, when the Chief Financial Officer of 

  

 -4- 

 
Natus Medical Incorporated remains as such following a Change of Control and is not made the Chief Financial Officer of the acquiring corporation) shall not
constitute “Good Reason;” (ii) a material reduction by the Company in Executive’s annual Base Salary as in effect immediately prior to such reduction; (iii) a material reduction by the Company in the kind or level of
employee benefits to which Executive is entitled immediately prior to such reduction with the result that Executive’s overall benefits package is significantly reduced; (iv) the relocation of Executive’s primary place of work to a
facility or a location that increases Executive’s commute distance by more than 35 miles from Executive’s then primary place of work (the parties acknowledge that there is currently uncertainty regarding application of Section 409A of
the Code in this area and agree that if later legal authority indicates this distance is not “material” that the distance shall automatically increase to such distance as has been determined to be the minimum required to be
“material”); or (v) the material breach of this Agreement by the Company (including, but not limited to, failure of the Company to obtain the assumption of this Agreement by any successors contemplated in Section 12). 

10. Confidential Information. Executive agrees to enter into the Company’s standard Confidential Information and Invention
Assignment Agreement (the “Confidential Information Agreement”) upon commencing employment hereunder. 
 11. Conditional Nature of Severance Payments. 
 (a) Noncompete. Executive acknowledges that the nature
of the Company’s business is such that if Executive were to become employed by, or substantially involved in, the business of a competitor of the Company following the termination of Executive’s employment with the Company, it would be
very difficult for Executive not to rely on or use the Company’s trade secrets and confidential information. Thus, to avoid the inevitable disclosure of the Company’s trade secrets and confidential information, Executive agrees and
acknowledges that Executive’s right to receive the severance payments set forth in Section 7 (to the extent Executive is otherwise entitled to such payments) shall be conditioned upon Executive not directly or indirectly engaging in
(whether as an employee, consultant, agent, proprietor, principal, partner, stockholder, corporate officer, director or otherwise), nor having any ownership interest in or participating in the financing, operation, management or control of, any
person, firm, corporation or business that competes with Company or is a customer of the Company. Upon any breach of this section, all severance payments pursuant to this Agreement shall immediately cease. 
 (b) Non-Solicitation. Until the date eighteen (18) months after the termination of Executive’s employment with the
Company for any reason, Executive agrees not, either directly or indirectly, to solicit, induce, attempt to hire, recruit, encourage, take away, hire any employee of the Company or cause an employee to leave his or her employment either for
Executive or for any other entity or person. Additionally, Executive acknowledges that Executive’s right to receive the severance payments set forth in Section 7 (to the extent Executive is otherwise entitled to such payments) are
contingent upon Executive complying with this Section 10(b) and upon any breach of this section all severance payments pursuant to this Agreement shall immediately cease. 
 (c) Understanding of Covenants. Executive represents that Executive (i) is familiar with the foregoing covenants not to compete and not to solicit, and (ii) is fully aware of
Executive’s obligations hereunder, including, without limitation, the reasonableness of the length of time, scope and geographic coverage of these covenants. 
  

 -5- 

 12. Assignment. This Agreement will be binding upon and inure to the benefit of
(a) the heirs, executors and legal representatives of Executive upon Executive’s death and (b) any successor of the Company. Any such successor of the Company will be deemed substituted for the Company under the terms of this
Agreement for all purposes. For this purpose, “successor” means any person, firm, corporation or other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly acquires all or substantially
all of the assets or business of the Company. None of the rights of Executive to receive any form of compensation payable pursuant to this Agreement may be assigned or transferred except by will or the laws of descent and distribution. Any other
attempted assignment, transfer, conveyance or other disposition of Executive’s right to compensation or other benefits will be null and void. 
 13. Notices. All notices, requests, demands and other communications called for hereunder shall be in writing and shall be deemed given (i) on the date of delivery if delivered personally, (ii) one
(1) day after being sent by a well established commercial overnight service, or (iii) four (4) days after being mailed by registered or certified mail, return receipt requested, prepaid and addressed to the parties or their successors
at the following addresses, or at such other addresses as the parties may later designate in writing: 
 If to the Company:

 Natus Medical Incorporated 
 1501 Industrial Road 
 San Carlos, CA 94070 
 Attn: [Name] 
 If to Executive: 
 at the last residential address known by the Company. 
 14. Severability. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be
illegal, unenforceable or void, this Agreement will continue in full force and effect without said provision. 
 15.
Arbitration. 
 (a) General. In consideration of Executive’s service to the Company, its promise to
arbitrate all employment related disputes and Executive’s receipt of the compensation, pay raises and other benefits paid to Executive by the Company, at present and in the future, Executive agrees that any and all controversies, claims, or
disputes with anyone (including the Company and any employee, officer, director, shareholder or benefit plan of the Company in their capacity as such or otherwise) arising out of, relating to, or resulting from Executive’s service to the
Company under this Agreement or otherwise or the termination of Executive’s service with the Company, including any breach of this Agreement, shall be subject to binding arbitration under the Arbitration Rules set forth in California Code of
Civil Procedure Section 1280 through 1294.2, including Section 1283.05 (the “Rules”) and pursuant to California law. Disputes which Executive agrees to arbitrate, and thereby agrees to waive any right to a trial by jury,
include any 

  

 -6- 

 
statutory claims under state or federal law, including, but not limited to, claims under Title VII of the Civil Rights Act of 1964, the Americans with
Disabilities Act of 1990, the Age Discrimination in Employment Act of 1967, the Older Workers Benefit Protection Act, the California Fair Employment and Housing Act, the California Labor Code, claims of harassment, discrimination or wrongful
termination and any statutory claims. Executive further understands that this Agreement to arbitrate also applies to any disputes that the Company may have with Executive. 
 (b) Procedure. Executive agrees that any arbitration will be administered by the American Arbitration Association (“AAA”) and that a neutral arbitrator will be selected in
a manner consistent with its National Rules for the Resolution of Employment Disputes. The arbitration proceedings will allow for discovery according to the rules set forth in the National Rules for the Resolution of Employment Disputes or
California Code of Civil Procedure. Executive agrees that the arbitrator shall have the power to decide any motions brought by any party to the arbitration, including motions for summary judgment and/or adjudication and motions to dismiss and
demurrers, prior to any arbitration hearing. Executive agrees that the arbitrator shall issue a written decision on the merits. Executive also agrees that the arbitrator shall have the power to award any remedies, including attorneys’ fees and
costs, available under applicable law. Executive understands the Company will pay for any administrative or hearing fees charged by the arbitrator or AAA except that Executive shall pay the first $200.00 of any filing fees associated with any
arbitration Executive initiates. Executive agrees that the arbitrator shall administer and conduct any arbitration in a manner consistent with the Rules and that to the extent that the AAA’s National Rules for the Resolution of Employment
Disputes conflict with the Rules, the Rules shall take precedence. 
 (c) Remedy. Except as provided by the Rules,
arbitration shall be the sole, exclusive and final remedy for any dispute between Executive and the Company. Accordingly, except as provided for by the Rules, neither Executive nor the Company will be permitted to pursue court action regarding
claims that are subject to arbitration. Notwithstanding, the arbitrator will not have the authority to disregard or refuse to enforce any lawful Company policy, and the arbitrator shall not order or require the Company to adopt a policy not
otherwise required by law that the Company has not adopted. 
 (d) Availability of Injunctive Relief. In addition to
the right under the Rules to petition the court for provisional relief, Executive agrees that any party may also petition the court for injunctive relief where either party alleges or claims a violation of this Agreement or the Confidentiality
Agreement or any other agreement regarding trade secrets, confidential information, nonsolicitation or Labor Code §2870. In the event either party seeks injunctive relief, the prevailing party shall be entitled to recover reasonable costs and
attorneys’ fees. 
 (e) Administrative Relief. Executive understands that this Agreement does not prohibit
Executive from pursuing an administrative claim with a local, state or federal administrative body such as the Department of Fair Employment and Housing, the Equal Employment Opportunity Commission or the workers’ compensation board. This
Agreement does, however, preclude Executive from pursuing court action regarding any such claim. 
 (f) Voluntary Nature
of Agreement. Executive acknowledges and agrees that Executive is executing this Agreement voluntarily and without any duress or undue influence by the Company or anyone else. Executive further acknowledges and agrees 

  

 -7- 

 
that Executive has carefully read this Agreement and that Executive has asked any questions needed for Executive to understand the terms, consequences and
binding effect of this Agreement and fully understand it, including that Executive is waiving Executive’s right to a jury trial. Finally, Executive agrees that Executive has been provided an opportunity to seek the advice of an attorney of
Executive’s choice before signing this Agreement. 
 16. Integration. This Agreement, together with the Option
Plan, Option Agreement and the Confidential Information Agreement represents the entire agreement and understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral.
No waiver, alteration, or modification of any of the provisions of this Agreement will be binding unless it is in writing and specifically mentions this Section 16 and it is signed by duly authorized representatives of the parties hereto.

 17. Waiver of Breach. The waiver of a breach of any term or provision of this Agreement, which must be in writing,
shall not operate as or be construed to be a waiver of any other previous or subsequent breach of this Agreement. 
 18.
Headings. All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement. 
 19. Tax Withholding. All payments made pursuant to this Agreement will be subject to withholding of applicable taxes. 
 20. Governing Law. This Agreement will be governed by the laws of the State of California (with the exception of its conflict of laws provisions). 
 21. Acknowledgment. Executive acknowledges that he has had the opportunity to discuss this matter with and obtain advice from his
private attorney, has had sufficient time to, and has carefully read and fully understands all the provisions of this Agreement, and is knowingly and voluntarily entering into this Agreement. 
 22. Counterparts. This Agreement may be executed in counterparts, and each counterpart shall have the same force and effect as an
original and shall constitute an effective, binding agreement on the part of each of the undersigned. 
 [Remainder of Page
Intentionally Left Blank] 
  

 -8- 

 IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the
Company by their duly authorized officers, as of the day and year first above written. 
  

									
	 COMPANY:
	 		 		 	
				
	 NATUS MEDICAL INCORPORATED
	 		 		 	
					
	 By:
	 	  
	 		 	 Date:
	 	  

					
	 Title:
	 	  
	 		 		 	

  

									
	 EXECUTIVE:
	 		 		 	
				
	  
	 		 	 Date:
	 	  

	 [Executive]
	 		 		 	

  

 -9-Third Amendment to Amended & Restated Credit Agreement - Wells Fargo Bank, N.A.

 EXECUTION VERSION 
 EXHIBIT 10.16 
 THIRD
AMENDMENT TO 
 AMENDED AND RESTATED CREDIT
AGREEMENT 
 THIS THIRD AMENDMENT TO
AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) is entered into as of February 19, 2009, between NATUS MEDICAL
INCORPORATED, a Delaware corporation (“Borrower”), and WELLS FARGO BANK, NATIONAL ASSOCIATION (“Bank”). 
 RECITALS 
 WHEREAS Borrower is currently indebted to Bank pursuant to the terms and conditions of the Amended and Restated Credit Agreement, dated as of November 28, 2007 (as amended, modified or supplemented prior to the date
hereof, the “Credit Agreement”), between Borrower and Bank; and 
 WHEREAS Borrower has
informed Bank that it desires to incur additional indebtedness and it desires to receive Bank’s consent to incur such indebtedness; and 
 WHEREAS Bank and Borrower have agreed to certain changes in the terms and conditions set forth in the Credit Agreement and have agreed to amend the Credit Agreement to reflect such changes; 

NOW, THEREFORE, for valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, Bank and Borrower hereby agree that the Credit Agreement shall be amended as follows; provided that nothing contained herein shall terminate any security interests, guaranties, subordinations or other documents in favor of Bank,
all of which shall remain in full force and effect unless expressly amended hereby: 
 Section 1. Definitions.
Each capitalized term used but not otherwise defined herein has the meaning assigned to it in the Credit Agreement. 
 Section 2. Amendments to Credit Agreement. Subject to Section 3 hereof, the Credit Agreement is hereby amended as follows: 
 (a) The definition of “Permitted Indebtedness” contained in Section 1.1 of the Credit Agreement is hereby amended to add immediately after paragraph (f) thereof the following:

 “; and 
 (g) that certain letter of credit number NZS635870 issued by Bank in the amount of Eighty Two Thousand One Hundred and Forty-Five Dollars ($82,145) for the benefit of J.P. Morgan Chase, London,
pursuant to documentation in form and substance satisfactory to Bank in its sole and absolute discretion. 

 Section 3. Conditions Precedent. This Amendment, including, without
limitation the amendments to the Credit Agreement contained herein, shall become effective as of the date first set forth above (the “Effective Date”) upon satisfaction of all of the conditions set forth in this Section 3 to
the satisfaction of Bank; provided that, in the event such conditions are not so satisfied, then this Amendment shall be of no further force and effect: 
 (a) Bank shall have received each of the following, duly executed and delivered by each of the applicable parties thereto: 
 (i) this Amendment together with the Consent and Reaffirmation attached hereto; 
 (ii) the Standby Letter of Credit Agreement, dated as of the date hereof, executed by the Company; 
 (iii) the Amended and Restated Security Agreement, dated as of the date hereof, executed by the Company in favor of Bank;
and 
 (iv) such other documents as Bank may require under any other Section of this Amendment; and

 (b) No Event of Default or event which, with the giving of notice, the lapse of time or both would
constitute an Event of Default, shall have occurred and be continuing. 
 Section 4. Interpretation. Except as
specifically provided herein, all terms and conditions of the Credit Agreement remain in full force and effect, without waiver or modification. This Amendment and the Credit Agreement shall be read together, as one document. The Recitals hereto,
including the terms defined therein, are incorporated herein by this reference and acknowledged by Borrower to be true, correct and complete. 
 Section 5. Representations, Warranties and Covenants. Borrower hereby remakes all representations and warranties contained in the Credit Agreement and reaffirms all covenants set forth therein (as amended
hereby) as of the date of this Amendment. Borrower further certifies that as of the date of this Amendment there exists no Event of Default, nor any condition, act or event which with the giving of notice or the passage of time or both would
constitute an Event of Default. 
 Section 6. Further Assurances. Borrower will make, execute, endorse,
acknowledge, and deliver any agreements, documents, or instruments, and take any and all other actions, as may from time to time be reasonably requested by Bank to perfect and maintain the validity and priority of the liens and security interests
granted to Bank pursuant to the Credit Agreement and the other Loan Documents and to effect, confirm, or further assure or protect and preserve the interests, rights, and remedies of Bank under the Credit Agreement (as amended hereby) and the other
Loan Documents. 
  

 - 2 - 

 Section 7. Counterparts. This Amendment may be executed in any number of
identical counterparts, any set of which signed by all the parties hereto shall be deemed to constitute a complete, executed original for all purposes. Delivery of an executed counterpart of a signature page of this Amendment by telefacsimile
transmission shall be as effective as delivery of a manually executed counterpart hereof. 
 Section 8. Governing
Law. This Amendment shall be governed by and construed in accordance with the internal laws of the State of California. 
 [Signatures
follow on next page.] 
  

 - 3 - 

 IN WITNESS WHEREOF, the parties hereto have
caused this Amendment to be executed as of the date first written above. 
  

									
	 NATUS MEDICAL INCORPORATED,
 a Delaware corporation
	 		 	 WELLS FARGO BANK,
 NATIONAL ASSOCIATION

					
	 By:
	 	 /s/ Steven J. Murphy
	 		 	 By:
	 	 /s/ Alicia Kachmarik

	 Name:
	 	 Steven J. Murphy
	 		 	 Name:
	 	 Alicia Kachmarik

	 Title:
	 	Vice President Finance and Chief Financial Officer	 		 	 Title:
	 	 Assistant Vice President

 CONSENT AND REAFFIRMATION 
 Each of the undersigned, a subsidiary of Natus Medical Incorporated (“Borrower”) who has executed a Continuing Guaranty
in favor of Wells Fargo Bank, National Association (“Bank”), hereby: (i) consents to the foregoing Third Amendment to Amended and Restated Credit Agreement; (ii) reaffirms its obligations under its respective Continuing
Guaranty; (iii) reaffirms the waivers of each and every one of the defenses to such obligations as set forth in such Continuing Guaranty; and (iv) reaffirms that its obligations under such Continuing Guaranty are separate and distinct from
the obligations of any other party under the Credit Agreement (as modified by the Third Amendment to Amended and Restated Credit Agreement) and the other Loan Documents. 
 Dated as of February 19, 2009 
 GUARANTOR: 
  

									
	NATUS ACQUISITION CORPORATION	 		 	NEUROCOM INTERNATIONAL, INC.
					
	 By:
	 	 /s/ Steven J. Murphy
	 		 	 By:
	 	 /s/ Steven J. Murphy

	 Name:
	 	 Steven J. Murphy
	 		 	 Name:
	 	 Steven J. Murphy

	 Title:
	 	 Chief Financial Officer
	 		 	 Title:
	 	 Chief Financial Officer

 CONSENT AND REAFFIRMATION

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}]]